{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:03:17Z","timestamp":1782572597630,"version":"3.54.5"},"reference-count":12,"publisher":"Stichting Nase","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rhin"],"DOI":"10.4193\/rhin21.359","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T10:34:28Z","timestamp":1645094068000},"page":"0-0","source":"Crossref","is-referenced-by-count":2,"title":["Respiratory epithelial adenomatoid hamartoma with nasal polyps affects dupilumab efficacy"],"prefix":"10.4193","volume":"0","author":[{"given":"T.","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Otori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2708","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Gandhi NA, Pirozzi G, Graham NM. Commonality of the IL-4\/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol. 2017 May;13(5):425-437.","DOI":"10.1080\/1744666X.2017.1298443"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (liberty np SINUS-24 and LIBERTY np sinus-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019 Nov 2;394(10209):1638-1650.","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Hopkins C, Wagenmann M, Bachert C, et al. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021 Jul;11(7):1087-1101.","DOI":"10.1002\/alr.22780"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in Chronic Rhinosinusitis with nasal polyps. J Asthma Allergy. 2021 Feb 11;14:127-134.","DOI":"10.2147\/JAA.S290424"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Schwitzgu\u00e9bel AJ-P, Jandus P, Lacroix J-S, Seebach JD, Harr T. Immunoglobulin deficiency in patients with chronic rhinosinusitis: Systematic review of the literature and meta-analysis. J Allergy Clin Immunol. 2015 Dec; 136(6):1523-1531.","DOI":"10.1016\/j.jaci.2015.07.016"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Miwa T, Ikeda K, Ishibashi T, et al. Clinical practice guidelines for the management of olfactory dysfunction - Secondary publication. Auris Nasus Larynx. 2019 Oct;46(5):653-662.","DOI":"10.1016\/j.anl.2019.04.002"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009 Oct;34(5):447-454.","DOI":"10.1111\/j.1749-4486.2009.01995.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Fitzhugh VA, Mirani N. Respiratory epithelial adenomatoid hamartoma: a review. Head Neck Pathol. 2008 Sep;2(3):203-8.","DOI":"10.1007\/s12105-008-0064-3"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Wenig BM, Heffner DK. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract and nasopharynx: a clinicopathologic study of 31 cases. Ann Otol Rhinol Laryngol. 1995 Aug;104(8):639-645.","DOI":"10.1177\/000348949510400809"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Nguyen DT, Jankowski R, Bey A, et al. Respirator y Epithelial Adenomatoid Hamartoma is Frequent in Olfactory Cleft After Nasalization. Laryngoscope. 2020 Sep;130(9):2098-2104.","DOI":"10.1002\/lary.28298"},{"key":"ref10","unstructured":"11. Lima NB, Jankowski R, Georgel T, Grignon B, Guillemin F, Vignaud JM. Respiratory adenomatoid hamartoma must be suspected on CT-scan enlargement of the olfactory clefts. Rhinology. 2006 Dec;44(4):264-9."},{"key":"ref11","unstructured":"12. Corren J, Castro M, O'Riordan T, et al. Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma. J Allergy Clin Immunol Pract. 2020 Feb;8(2):516-526."}],"container-title":["Rhinology journal"],"original-title":[],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T10:37:37Z","timestamp":1645094257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rhinologyjournal.com\/Abstract.php?id=2967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":12,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2022,2,17]]}},"URL":"https:\/\/doi.org\/10.4193\/rhin21.359","relation":{},"ISSN":["0300-0729"],"issn-type":[{"value":"0300-0729","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}